Namdeo JADHAV, Rani DHOLE, Udaykumar PATIL

Stabilization of hydrochlorothiazide nanocrystals using fibroin

Nanocrystals of the poorly water soluble drugs is a promising strategy. To stabilize the drug nanocrystals, stabilizers are usually used; however, the use of common stabilizers is limited by weak stabilization effect and toxicological concerns for long-term treatment. The present work was aimed to investigate the potential of natural silk protein as novel stabilizer for nanocrystal of hydrochlorothiazide, which was a model drug. The nanocrystals of drug with hydrophobic protein stabilizer were prepared by antisolvent precipitation method. Prepared nanocrystals were evaluated for parameters like particle size, zeta potential, DSC, XRD, %crystallinity, SEM, drug content and in vitro dissolution test. Stabilization efficiency of nanocrystals was assessed by their % crystallinity for 3 months. Optimized batch R2 was shown smaller particle size, highest drug content and drug dissolution. Nanocrystals were shown the extended release due to coat of fibroin around the hydrochlorothiazide. From the % crystallinity study it was found that there was not significant change in the nanocrystals prepared using fibroin. So, it was concluded that the fibroin is good stabilizer for drug nanocrystals.

PDF

___

Katteboina S, Chandrasekhar P, Balaji S. Drug nanocrystals: a novel formulation approach for poorly soluble drugs. Int J Pharm Tech Res. 2009; 1(3): 682-694.
Patravale V, Date A, Kulkarni R. Nanosuspensions a promising drug delivery strategy. J Pharm Pharmacol. 2004; 56: 827-840. [CrossRef]
Kale M,Mishra B. Drug nanocrystals: A way toward scale-up. Saudi Pharm J. 2016; 24(4): 386-404.[CrossRef]
Pawar V,Singh Y, Meher J, Gupta S, Chourasiya M. Engineered nanocrystal technology: in-vivo fate, targeting and applications in drug delivery. J Control Release. 2014; 183: 51-66. [CrossRef]
Buraphacheep V, Morakul B. Nanocrystals for enhancement of oral bioavailability of poorly water-soluble drugs. Asian J Pharm Sci. 2015; 13-23. [CrossRef]
Wei H, Ye L, Jianping Q, Lingyun C, Fuqiang H, Wei W. Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs. Int J Pharm. 2013; 441: 269-278. [CrossRef]
Cheng Y, Koh LD, Li D, Ji B, Hang MY, Zhang YW. On the strength of β-sheet crystallites of Bombyx mori silk fibroin. J R Soc Interface. 2014; 11: 1-9. [CrossRef]
Bajaj A, Rao M, Pardeshi A, Sali D. Nanocrystallization by Evaporative Antisolvent Technique for Solubility and Bioavailability Enhancement of Telmisartan. AAPS Pharm Sci Tech. 2012; 13(4): 1331-1340. [CrossRef]
Nanjwade B, Derkar G, Bechra H,Nanjwade V, Mani F. Design and Characterization of Nanocrystals of Lovastatin for Solubility and Dissolution Enhancement. J Nanomed Nanotechnol. 2011; 2: 107. [CrossRef]
Choi M, Briançon S, Andrieu J, Min S, Fessi H. Effect of freeze drying process conditions on the stability of nanoparticles. Dry Technol. 2004; 22: 335-346. [CrossRef]
Kakran M, Shegokar R, Sahoo NG, Shaal LA, Li L, Muller RH. Fabrication of quercetin nanocrystals: comparison of different methods. Eur J Pharm Biopharm. 2010; 80: 113-121. [CrossRef]
Lee J, Lee SJ, Choi JY, Yoo JY, Ahn CH. Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion. EurJ Pharm Sci 2005; 24(5): 441–449. [CrossRef]
Patel AP, Patel JK, Patel KS, Deshmukh AB, Mishra BR. A review on drug nanocrystal a carrier free drug delivery. Int J Res Ayurveda Pharm. 2(2), 448-458 (2011).
Peltonen, L. Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol. 2010; 62(11): 1569-1579. [CrossRef]